Nevirapine
- Generic Name
- Nevirapine
- Brand Names
- Viramune
- Drug Type
- Small Molecule
- Chemical Formula
- C15H14N4O
- CAS Number
- 129618-40-2
- Unique Ingredient Identifier
- 99DK7FVK1H
- Background
A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
- Indication
For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.
- Associated Conditions
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Associated Therapies
- -
A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients
- Conditions
- HIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-10-29
- Target Recruit Count
- 24
- Registration Number
- NCT00000896
- Locations
- 🇺🇸
Ucsd, Avrc Crs, San Diego, California, United States
🇺🇸University of Colorado Hospital CRS, Aurora, Colorado, United States
🇺🇸Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States
A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants
- Conditions
- HIV InfectionsPregnancy
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2021-11-01
- Target Recruit Count
- 2009
- Registration Number
- NCT00001135
- Locations
- 🇺🇸
Children's Hosp of Boston, Boston, Massachusetts, United States
🇺🇸Univ of Miami (Pediatric), Miami, Florida, United States
🇺🇸Duke Univ Med Ctr, Durham, North Carolina, United States
Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
- Conditions
- HIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2017-07-02
- Target Recruit Count
- 42
- Registration Number
- NCT00001644
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.